Fjarde Ap-fonden’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-62,151
Closed -$4.98M 630
2016
Q4
$4.98M Sell
62,151
-5,992
-9% -$476K 0.12% 198
2016
Q3
$5.43M Buy
68,143
+1,951
+3% +$158K 0.12% 200
2016
Q2
$5.16M Buy
66,192
+1,310
+2% +$93.4K 0.12% 198
2016
Q1
$3.57M Buy
64,882
+8,173
+14% +$445K 0.08% 273
2015
Q4
$3.52M Buy
56,709
+1,331
+2% +$83.9K 0.09% 249
2015
Q3
$3.51M Sell
55,378
-3,958
-7% -$282K 0.1% 237
2015
Q2
$4.35M Sell
59,336
-4,920
-8% -$355K 0.11% 220
2015
Q1
$4.22M Sell
64,256
-3,070
-5% -$204K 0.1% 250
2014
Q4
$4.4M Sell
67,326
-6,466
-9% -$416K 0.1% 254
2014
Q3
$4.46M Sell
73,792
-5,704
-7% -$373K 0.1% 240
2014
Q2
$5.53M Sell
79,496
-4,723
-6% -$306K 0.11% 214
2014
Q1
$5.53M Buy
84,219
+5,732
+7% +$373K 0.11% 209
2013
Q4
$4.88M Sell
78,487
-5,825
-7% -$337K 0.1% 220
2013
Q3
$4.54M Sell
84,312
-6,914
-8% -$356K 0.1% 238
2013
Q2
$4.18M Buy
+91,226
New +$3.95M 0.09% 273

Other funds holding STJ

Fjarde Ap-fonden's STJ Position: Q1 2017 in Review

Fjarde Ap-fonden sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 62,151 shares — an estimated $4.98M sold.

Fjarde Ap-fonden first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $5.53M in Q1 2014. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Fjarde Ap-fonden reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Fjarde Ap-fonden sold 62,151 St Jude Medical shares in Q1 2017, an estimated $4.98M.
  • Fjarde Ap-fonden first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Fjarde Ap-fonden's St Jude Medical position peaked at $5.53M in Q1 2014.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Fjarde Ap-fonden's 13F filing for Q1 2017, filed 10 May 2017.